Vera Therapeutics Inc (VERA US, +N, 26-Jun-25)
Patrick Enright (Non-Executive since 2020) bought $ 5.3 million of stock on 24th June at $ 21.11, increasing his stake by 5%. The purchases were indirect and on behalf of Longitude Capital, where he is co-founder and Managing Director. The purchase takes their stake to 8.5%. While he has made 3 subscriptions since joining in 2020, this is his first open-market purchase.
The most recent subscription was at $7 in September 2023, and it’s encouraging that he is now buying at 3x the price 2 years later. Their initial investment in October 2020 was $15 million in preferred shares, prior to the May 2021 IPO, which converted to 2.2 million common shares at the time of the IPO.
We are ranking the stock +N (notable and positive signal).
If you want the Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe! Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.
